A Open-label, Single-dose, 2-Sequence, 2-Period, Crossover Study to Assess Safety and Pharmacokinetics of a Nateglinide/Metformin HCl Combined Tablet Compared With a Nateglinide 120 mg Tablet and Metformin HCl 500 mg Tablet Under Fasting Conditions in Healthy Male Subjects

Name: A Open-label, Single-dose, 2-Sequence, 2-Period, Crossover Study to Assess Safety and Pharmacokinetics of a Nateglinide/Metformin HCl Combined Tablet Compared With a Nateglinide 120 mg Tablet and Metformin HCl 500 mg Tablet Under Fasting Conditions in Healthy Male Subjects
License: Public Domain

IlDong Pharmaceutical Co Ltd

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

healthy volunteers

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 272312
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.